QHM-2025-8523 A86006 Roseworth Surgery Enhanced Services Contract

" This contract falls under the health services industry category, with specific services including SMI Health Checks, Denosumab Injections, Diabetes management, among others. Located in the UKC region, specifically Sunderland and Newcastle upon Tyne, the procurement has advanced to the award stage as of 11 October 2025. The contract, effective from 1 April 2025 and ending on 31 March 2026, has gone through the Direct Award Process A, which aligns with the Health Care Services (Provider Selection Regime) regulations 2023.

This process does not fall under the Procurement Act 2023, thereby bypassing certain procurement regulations. The procurement method was limited, specifically described as an award procedure without prior publication of a call for competition. This tender represents a lucrative opportunity for businesses involved in providing health services, particularly those capable of delivering the specified enhanced services.

Companies with prior experience and capacity to manage services such as mental health checks, care home support, and diabetes shared care would find this contract aligns well with their expertise. Despite the contract value being activity-based with no guaranteed sum, successful bidders, like the current awardee Roseworth Surgery, can anticipate steady engagements throughout the contract period. This opportunity is ideal for large-scale health service providers that are already established in the region, given there is a noted absence of realistic alternative providers, which suggests limited competition and a stable demand for services.